To investigate the role of the individual pro-survival proteins inhibited by AZD4320/navitoclax in melanoma, we used selective inhibitors of BCL2 (venetoclax, ABT-199) and BCL-XL (A-1155463)37. The gene discussed is BCL2L1; the disease is melanoma.